Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Olcina

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The British Journal of Radiology|December 17, 2014
Targeting chromatin to improve radiation responseM M Olcina, S O'Dell, E M Hammond
Oncogene|May 12, 2015
H3K9me3 facilitates hypoxia-induced p53-dependent apoptosis through repression of APAKM M Olcina, K B Leszczynska, J M Senra, et al.
British Journal of Cancer|June 21, 2012
Targeting radiation-resistant hypoxic tumour cells through ATR inhibitionI M Pires, M M Olcina, S Anbalagan, et al.
Cell Death & Disease|December 11, 2012
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiationE Fokas, R Prevo, J R Pollard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 9, 2025
Systemic complement protein levels as biomarkers of chemoradiotherapy response in anal squamous cell carcinomaD Majorova, R Samuel, R Muirhead, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The British Journal of Radiology|December 17, 2014
Targeting chromatin to improve radiation responseM M Olcina, S O'Dell, E M Hammond
Oncogene|May 12, 2015
H3K9me3 facilitates hypoxia-induced p53-dependent apoptosis through repression of APAKM M Olcina, K B Leszczynska, J M Senra, et al.
British Journal of Cancer|June 21, 2012
Targeting radiation-resistant hypoxic tumour cells through ATR inhibitionI M Pires, M M Olcina, S Anbalagan, et al.
Cell Death & Disease|December 11, 2012
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiationE Fokas, R Prevo, J R Pollard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 9, 2025
Systemic complement protein levels as biomarkers of chemoradiotherapy response in anal squamous cell carcinomaD Majorova, R Samuel, R Muirhead, et al.
Pageof 1